Literature DB >> 2652777

Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survival.

P D Greig1, G M Woolf, M Abecassis, S M Strasberg, B Taylor, R A Superina, B Langer, M F Glynn, M Ettles, L Blendis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2652777

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1.

Authors:  A Azzarone; A Francavilla; G Carrieri; A Gasbarrini; C Scotti-Foglieni; S Fagiuoli; U Cillo; Q H Zeng; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  The Effect and Safety of Prostaglandin Administration in Pediatric Liver Transplantation.

Authors:  Céline Lironi; Valérie A McLin; Barbara E Wildhaber
Journal:  Transplant Direct       Date:  2017-05-18

Review 3.  Liver cytoprotection by prostaglandins.

Authors:  J Quiroga; J Prieto
Journal:  Pharmacol Ther       Date:  1993       Impact factor: 12.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.